Tissue Banking Market 2022-2027: Industry Analysis, Size, Share, Trends and Outlook

According to the latest report by IMARC Group, titled "Tissue Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," The global tissue banking market reached a value of US$ 1.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.83 Billion by 2027, exhibiting at a CAGR of 11.9% during 2022-2027.

Report Metric

Historical: 2016-2021

Base Year: 2021

Forecast Year: 2022-2027

Download free sample of the report: https://www.imarcgroup.com/tissue-banking-market/requestsample

Tissue Banking Market Industry Definition and Application:

Tissue banking represents the process of preparing, collecting, and preserving transplantable human tissues for potential therapeutic uses. The tissues obtained are used in replacing and healing the affected or lost tissues of the patients. In line with this, they are also utilized to repair damaged heart muscles, treat spinal cord injuries, heal skin from severe burns, etc. Presently, there are numerous advancements in clinical trials and biomedical research. Consequently, tissue preservation and banking is gaining extensive traction across the globe.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Tissue Banking Market Trends and Drivers:

The expanding geriatric population and the sudden outbreak of the COVID-19 pandemic are primarily driving the tissue banking market. Additionally, the growing number of individuals undergoing surgical interventions is increasing the use of human tissue allografts that are adopted to repair limbs, relieve pain, and improve the life quality of patients. Besides this, researchers are relying on tissue banks to understand cellular responses and the biological impact of infection, collect tissue specimens, identify new therapeutic interventions and prevention strategies, etc., which is acting as another significant growth-inducing factor. Moreover, the increasing popularity of tissue banks for the transplantation of tendons, corneas, bones, heart valves, skin, etc., is also positively influencing the global market. Apart from this, they can minimize the risk of bacterial and fungal contamination of tissues by using aseptic surgical equipment, techniques, and supplies while processing and storing the tissue from the donor. Furthermore, the emerging trend of cosmetic surgeries, on account of the inflating disposable income levels and the rising consumer consciousness towards physical appearances, is anticipated to fuel the tissue banking market over the forecasted period.

Browse full report with TOC: https://www.imarcgroup.com/tissue-banking-market

Tissue Banking Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The report has segmented the market on the basis on region, product, application, tissue type.

Breakup by Product:

Equipment
Cryopreservation Equipment
Thawing Equipment
Quality Control Equipment
Others
Media and Consumables

Breakup by Application:

Therapeutics
Medical Research
Others

Breakup by Tissue Type:

Cardiovascular Tissue
Lung Tissue
Kidney Tissue
Pancreas Tissue
Liver Tissue
Eye Tissue
Others

Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Who are the Major Tissue Banking Market Key players?

The report provides a detailed analysis of the market leaders, including.

AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., and VWR International LLC (Avantor Inc).

Related Report by IMARC Group:

Aerosol Delivery Devices Market Report: https://www.imarcgroup.com/aerosol-delivery-devices-market

Onychomycosis Treatment Market Report: https://www.imarcgroup.com/onychomycosis-treatment-market

Lateral Flow Assay Market Report: https://www.imarcgroup.com/lateral-flow-assay-market

Formulation Development Outsourcing Market Report: https://www.imarcgroup.com/formulation-development-outsourcing-market

Drug Device Combination Products Market Report: https://www.imarcgroup.com/drug-device-combination-products-market

Nanopore Technologies Market Report: https://www.imarcgroup.com/nanopore-technologies-market

Pyrogen Testing Market Report: https://www.imarcgroup.com/pyrogen-testing-market

Nuclear Medicine Equipment Market Report: https://www.imarcgroup.com/nuclear-medicine-equipment-market

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.